Gastric cancer – ASCO 2009

被引：0

作者：

Ewald Wöll

机构：

[1] St. Vinzenz Hospital Zams,

来源：

memo - Magazine of European Medical Oncology | 2009年 / 2卷 / 4期

关键词：

Gastric cancer; neoadjuvant therapy; adjuvant therapy; trastuzumab; cetuximab; bevacizumab;

D O I：

10.1007/s12254-009-0161-3

中图分类号：

学科分类号：

摘要：

Individualized tumour therapy was the leading theme of this year's ASCO. In this context Her2Neu testing could detect a subgroup of patients suffering from advanced gastric cancer who showed substantial benefit from the addition of trastuzumab to standard chemotherapy. This first phase III trial with a biological agent is the beginning of individualized tumour therapy in gastric cancer. These data will be discussed together with other abstracts from ASCO 2009 and set into context with current therapeutic strategies.

引用

页码：206 / 207

页数：1

共 50 条

[1] Gastric cancer - ASCO 2009
Woell, E.
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (04) : 206 - 207
[2] Oesophageal cancer - ASCO 2009
Eisterer, W.
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (04) : 221 - 222
[3] Pancreatic cancer – ASCO 2009
Georg Pall
[J]. memo - Magazine of European Medical Oncology, 2009, 2 (4) : 211 - 213
[4] Pancreatic cancer - ASCO 2009
Pall, G.
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (04) : 211 - 213
[5] Oesophageal cancer – ASCO 2009
Wolfgang Eisterer
[J]. memo - Magazine of European Medical Oncology, 2009, 2 (4) : 221 - 222
[6] ASCO update: gastric cancer
Wöll E.
[J]. memo - Magazine of European Medical Oncology, 2016, 9 (4) : 219 - 221
[7] Gastric cancer - ASCO 2010
Wöll E.
[J]. memo - Magazine of European Medical Oncology, 2010, 3 (4) : 168 - 170
[8] Treatment of colorectal cancer – ASCO 2009
Florian Lordick
[J]. memo - Magazine of European Medical Oncology, 2009, 2 (4) : 214 - 217
[9] Treatment of colorectal cancer - ASCO 2009
Lordick, F.
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (04) : 214 - 217
[10] Best of breast cancer - ASCO 2009
Eniu, A.
Morar-Bolba, G.
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (04) : 223 - 227

← 1 2 3 4 5 →